1

You have a vision of your future? What next. What you will discover in the pages of "COMMERCIAL OPPORTUNITIES IN APOPTOSIS" could make the difference between you company blazing a trail in apoptosis drug development or being left behind.

It's up to you to keep your company on the leading edge of new
discoveries...to bet the competition's R&D pipeline...and to grab
and control your company's future.

From our Emerging Technologies Group, "Commercial Opportunities in Apoptosis" is a comprehensive new report from CTB International Publishing, Inc., the leading source of intelligence on drug development. For over a decade, we have been keeping busy executives on top of what's happening through reports and our highly respected newsletters.

THE FUTURE IS HERE. Over 125 companies are already trying to harness apoptosis to make unprecedented breakthroughs in treating a wide range of diseases. Cancer...infectious and autoimmune diseases...neurodegenerative conditions...cardiovascular disorders.

Its over 200 pages provide you with...

• a thorough and up-to-date overview of research on apoptosis
• explanations of how apoptosis can be manipulated to treat
  diseases
• what diseases are being targeted, why, and by what companies
  profiles of what more than 125 companies are already doing in this
  burgeoning field
• a directory of companies involved in apoptosis -- with contact
  names, addresses, and phone and fax numbers
• a summary of useful review articles from the literature
• a comprehensive index of over 800 entries that includes
  companies, diseases, drugs, genes, etc.

this report pulls together into one, easy-to-use comprehensive volume everything you need to pinpoint the opportunities, avoid the pitfalls and beat the competition...

• 26 tables, including one that outlines more than 100 genes and
  gene products known to be involved in apoptosis
• tables illustrating which companies are targeting what diseases
  with apoptosis-based drugs
• a list of researchers in the field.

Don't be left behind. This report is the most up-to-date and comprehensive overview of who is studying apoptosis and how they are trying to convert that knowledge into pharmaceuticals.

• Is it too late for your company to benefit?
• Does your firm have the resources and scientific expertise to
  become a major player in the field?
• What directions are your competitors taking?

"Commercial Opportunities in Apoptosis" is your must-have resource to insure your company's stake in the future.